临床医学专业是一门实践性很强的应用科学专业,致力于培养具备基础医学.临床医学的基本理论和医疗预防的基本技能；能在医疗卫生单位.医学科研等部门从事医疗及预防.医学科研等方面工作的医学高级专门人才.本文以临床医学硕士论文为例,为大家精选优秀临床医学硕士论文6篇,供大家参考学习. 更多精彩就在： 51免费论文网|www.jxszl.com 
-align:center">第一篇临床医学硕士论文标题：冠状动脉介入手术术后采用益气活血方的疗效本篇文章目录导航：[]冠状动脉介入手术术后采用益气活血方的疗效[前言-第一章]益气活血方在冠心病术后应用临床资料[第二章]冠心病PIC术后中医治疗探究方法[第三章]PIC手术患者服用益气活血方的效果探究结果[第四章]益气活血方的有效性探讨[第五章-参考文献]心脏支架手术患者中药疗效探究结语与参考文献[综述1]冠心病及PCI术后中西医结合探究进展[综述2]李应东教授治疗冠心病经验简述中文摘要目的：观察益气活血方在常规西药基础上治疗冠心病PCI术后气虚血瘀证患者临床疗效及安全性,探索出中医药治疗PCI术后气虚血瘀证的有效方药,并优化辨证用药.方法：本探究选自2017年1月-2018年1月就诊于甘肃中医药大学附属医院心内科专家门诊的140例符合诊断标准的PCI术后气虚血瘀证患者作为探究对象,随机分为对照组和观察组.对照组常规西药治疗,观察组在对照组的治疗基础上服用益气活血方治疗15天.观察两组患者治疗前后中医证候疗效.心绞痛疗效.硝酸甘油减停率.心电图疗效.低密度脂蛋白.左室射血分数.6分钟步行试验.欧洲五维健康量表视觉模拟刻度尺(EQ-VAS)评分的改善情况,并用SPSS23.0软件进行剖析数据,计数资料用卡方检验,计量资料以均数±标准差(`X2±S)表示,采用t检验,等级资料用秩和检验,以评估益气活血方治疗PCI术后气虚血瘀证的临床疗效.结果：⑴中医证候疗效：治疗后观察组总有效率80.6%,对照组为29.4%,两组间比较有显着统计学意义(P＜0.001)；⑵心绞痛疗效：治疗后观察组总有效率81.9%,对照组为55.9%,其差异有显着统计学意义(P＜0.01)；⑶硝酸甘油减停率：治疗后观察组总有效率88.9%,对照组总有效率66.2%,组间比较有显着统计学意义(P＜0.01)；⑷心电图疗效：治疗后观察组总有效率72.2.%,对照组总有效率50%,其差异有统计学意义(P＜0.05)；⑸对LDL-c的影响：治疗后观察组与对照组无差异(P＞0.05)；⑹对左室射血分数(LVEF)的影响：治疗后观察组与对照组LVEF改善有显着性差异(P＜0.001)；⑺对6分钟步行试验的影响：治疗后观察组与对照组之间比较无统计学意义(P＞0.05)；⑻对欧洲五维健康量表视觉模拟刻度尺(EQ-VAS)评分的影响：治疗后观察组与对照组有显着统计学意义(P＜0.001).结论：本探究应用益气活血方,不仅显着改善患者气虚血瘀证的中医证候.缓解心绞痛.提高硝酸甘油减停率.改善心电图疗效,能够提高LVEF.提高欧洲五维健康量表视觉模拟刻度尺(EQ-VAS)评分,但对LDL-c和6MWD无显着改善.总体疗效确切,且未发现不良反应.关键字：PCI术后,益气活血方,气虚血瘀证,疗效观察AbstractPurpose:ToobservetheclinicalefficacyandsafetyofYiqiHuoxuePrescriptioninthetreatmentofcoronaryheartdiseasepatientswithqideficiencyandbloodstasissyndromeonthebasisofconventionalwesternmedicine,exploretheeffectiveprescriptionsofChinesemedicineforthetreatmentofQideficiencyandbloodstasissyndromeafterPCI,andoptimizetheuseofsyndromedifferentiationdrugs.Method:Thisstudywasselectedfrom140patientswithqideficiencyandbloodstasissyndromewhometthediagnosticcriteriaintheoutpatientdepartmentofcardiologyattheAffiliatedHospitalofGansuUniversityofTraditionalChineseMedicinefromJanuary2017toJanuary2018.TheywererandomlydividedintocontrolgroupandObservationgroup.ThecontrolgroupwastreatedwithconventionalWesternmedicine,andtheobservationgroupwastreatedwithYiqiHuoxuePrescriptiononthebasisofthetreatmentofthecontrolgroupfor15days.ObservetheefficacyofTCMsyndromebeforeandaftertreatment,theeffectofanginapectoris,thereductionofnitroglycerin,ECGefficacy,low-densitylipoprotein,leftventricularejectionfraction,6-minutewalkingtest,andEuropeanVdimensionhealthscalevisualanaloguescale(EQ-VAS))ImprovementsinscoreswereanalyzedusingSPSS23.0software.Chi-squaretestwasperformedonthecountdata.Measureddatawereexpressedasmean±standarddeviation(X2±S).Thet-testwasused.RankdatawereusedfortheranksumtesttoevaluateClinicalEffectofYiqiHuoxuePrescriptioninTreatingQiDeficiencyandBloodStasisSyndromeafterPCI.Result:(1)EfficacyofTCMsyndromes:Thetotaleffectiverateoftheobservationgroupaftertreatmentwas80.6%,andthatofthecontrolgroupwas29.4%.Therewasstatisticallysignificantdifferencebetweenthetwogroups(P<0.001);(2)Anginapectorisefficacy:Thetotaleffectiverateoftheobservationgroupaftertreatmentwas81.9%Thecontrolgroupwas55.9%,andthedifferencewasstatisticallysignificant(P<0.01).(3)Thenitroglycerinreductionrate:Thetotaleffectiveratewas88.9%intheobservationgroupand66.2%inthecontrolgroupaftertreatment.Therewasasignificantdifferencebetweenthegroups.Statisticalsignificance(P<0.01);4)EfficacyofECG:Thetotaleffectiverateoftheobservationgroupaftertreatmentwas72.2%,andthetotaleffectiverateofthecontrolgroupwas50%.Thedifferencewasstatisticallysignificant(P<0.05);(5)TheLDL-cEffects:Therewasnodifferencebetweentheobservationgroupandthecontrolgroupaftertreatment(P>0.05);(6)Effectonleftventricularejectionfraction(LVEF):TherewasasignificantdifferenceinimprovementofLVEFbetweentheobservationgroupandthecontrolgroupaftertreatment(P<0.001);(7)Effectsonthe6-minutewalkingtest:Therewasnosignificantdifferencebetweentheobservationgroupandthecontrolgroupaftertreatment(P>0.05);(8)EffectontheEQ-VASscoreoftheEuropeanFive-DimensionalHealthScale:observationgroupandcontrolgroupaftertreatmentTherewassignificantstatisticalsignificance(P<0.001).Conclusions:TheuseofYiqiHuoxuePrescriptioninthisstudynotonlysignificantlyimprovetheTCMsyndromesofpatientswithqideficiencyandbloodstasissyndrome,relieveanginapectoris,increasetherateofnitroglycerinreduction,improvetheefficacyofelectrocardiogram,improveLVEF,andincreasethevisualanaloguescaleofEuropeanfive-dimensionalhealthscale.(EQ-VAS)score,butnosignificantimprovementinLDL-cand6MWD,theoverallefficacywasdefinite,andnoadversereactionswerefound.Keywords:PostoperativePCI,YiqiHuoxuePrescription,QiDeficiencyandBloodStasisSyndrome,ObservationofCurativeEffect目录中文摘要ABSTRACT英文缩略词表前言第一章临床资料1.1一般资料1.2病例纳入标准1.3冠心病PCI术后中医证候诊断标准1.4病例排除标准1.5病例剔除及脱落标准1.6终止试验标准第二章探究方法2.1药品2.2分组与治法2.3观察指标2.4疗效判定标准2.5统计方法第三章结果3.1一般资料：年龄,性别.体重指数3.2两组患者中医证候疗效比较3.3两组患者心绞痛疗效比较3.4两组患者硝酸甘油减停率比较3.5两组患者心电图疗效比较3.6两组患者治疗前后低密度脂蛋白(LDL-C)比较3.7两组患者治疗前后左室射血分数(LVEF)比较3.8两组患者治疗前后6分钟步行试验(6MWT)结果比较3.9两组患者治疗前后欧洲五维健康量表视觉模拟刻度尺(EQ-VAS)评分比较3.10安全性检测及不良反应第四章探讨4.1PCI术及其中医认识4.2益气活血方来源及方解4.3益气活血方对PCI术后患者的疗效第五章结语5.1结论5.2不足与展望参考文献综述冠心病及PCI术后中西医结合探究进展1.冠心病的西医认识1.1冠心病概述1.2危险因素1.3发病机制1.4预防1.5治疗1.6PCI术目前治疗现状及困惑2.冠心病中医认识及PCI术后中医诊疗进展2.1病名2.2病因认识2.3病机认识2.4治法历史沿革2.5冠心病PCI术后病因病机2.6益气活血法治疗PCI术后探究进展3.结语李应东教授治疗冠心病经验简述1.注重治未病2.整体观视野下辨治冠心病3.中西医结合,辨病.辨证.辨体质结合4.阴阳气血同调5.身心同治6.从脾肾论治冠心病参考文献附表附表1.知情同意书附表2.受试者基本信息调查表附表3.中医证候积分表附表4.心绞痛积分表附表5.EQ-VAS在学期间的探究成果致谢
原文链接：http://www.jxszl.com/lwqt/mflw/22110.html